Safety Study of Injections of Autologous/Allogeneic TGFbeta-resistant LMP2A-specific Cytotoxic T-lymphocytes (CTL) (TGF-beta)
This study is currently recruiting participants.
Verified August 2012 by Baylor College of Medicine
Sponsor:
Baylor College of Medicine
Collaborators:
Texas Children's Hospital
The Methodist Hospital System
Center for Cell and Gene Therapy, Baylor College of Medicine
Information provided by (Responsible Party):
catherine bollard, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT00368082
First received: August 22, 2006
Last updated: August 29, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2030 |
| Estimated Primary Completion Date: | December 2015 (Final data collection date for primary outcome measure) |